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Background: Using a large contemporary database of pts with STEMI undergoing primary PCI, we sought to examine whether a relationship exists 
between B-type natriuretic peptide (BNP) and the development of contrast induced nephropathy (CIN).
Methods: A total of 2975 STEMI pts in the HORIZONS-AMI trial had available data on serum creatinine concentrations after angiography, 979 of 
whom also had BNP levels measured in the emergency room as part of the study protocol. CIN was defined as a relative increase in creatinine of 
≥25%, or an absolute increase in creatinine of ≥0.5 mg/dL within 48 hours after primary PCI. Logistic regression analysis was used to estimate the 
association of admission BNP with development of CIN.
Results: CIN occurred in 131 (13.3%) of pts. Increasing BNP was a significant univariable correlate of CIN (OR 1.40, 95% CI: 1.09 - 1.80; 
p=0.009). In multivariable analysis including clinical, laboratory and angiographic variables BNP was a significant independent predictor of CIN 
(Table). Furthermore, significant net reclassification improvement was achieved by addition of BNP to the Mehran Risk Score (NRI: 0.028; p=0.002) 
and to a clinical risk prediction model (NRI: 0.022; p=0.03).
Conclusions: Measurement of BNP concentrations at hospital admission may help identify pts at risk of CIN after primary PCI in STEMI.
Table 
Estimate Std.Err. Odds Ratio p value
BNP 0.442 0.151 1.56 [ 1.16. 2.09] 0.0034
Systolic blood pressure -0.006 0.004 0.99 [ 0.99. 1.00] 0.1459
Age 0.661 0.129 1.94 [ 1.51. 2.49] <0.0001
Creatinine Clearance 0.017 0.004 1.02 [ 1.01. 1.02] <0.0001
History of prior MI 0.841 0.328 2.32 [ 1.22. 4.41] 0.0103
LVEF -0.026 0.008 0.97 [ 0.96. 0.99] 0.0017
History of renal insufficiency 1.174 0.479 3.24 [ 1.27. 8.27] 0.0142
